Not Signed In - ATS Medical Announces ATS 3f(R) Aortic Bioprosthesis PMA Filing
Tue, 07 Nov 2006 08:00 AM EST
... ATS Medical, Inc. (Nasdaq: ATSI) -- today announced that The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has completed an initial review of their premarket approval application (PMA) for the ATS 3f(R) Aortic Bioprosthesis Heart Valve. [click link for full article] ...
Related Topics
- Heart Valve Diseases
- Drug and Medical Device Safety
- Andersen-Tawil syndrome
- Understanding Medical Research
- Medical Care
- Medical Errors
- Medical Education & Training
- Emergency Medical Services
- Aneurysms
- Diagnosis
- Personal Medical Records
- Medical acupuncture
- Genetic Counseling
- Aortic rupture
- Aortic aneurysm
- Aortic dissection
- Aortic insufficiency
- Medical intuition
- Aortic Valve Insufficiency
- Thoracic aortic aneurysm
email this page
print this page
bookmark this page
feedback on this page
